Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 3/20 | 0.40 |
| ▸ | ESR2 | Q92731 | 3/20 | 0.40 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.39 |
| ▸ | HSD17B1 | P14061 | 2/20 | 0.38 |
| ▸ | HSD17B2 | P37059 | 2/20 | 0.38 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.35 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.35 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.35 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.35 |
| ▸ | ACMSD | Q8TDX5 | 1/20 | 0.34 |
| ▸ | ERN1 | O75460 | 1/20 | 0.34 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.33 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.33 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.33 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.33 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10122762 | 0.94 | ESR1 (0.41) | ESR1ESR2ALOX5HSD17B1HSD17B2 | |
| SCHEMBL10122758 | 0.91 | HSD17B1 (0.45) | ESR1ESR2ALOX5HSD17B1HSD17B2 | |
| SCHEMBL18116152 | 0.91 | ESR1 (0.46) | ESR1ESR2ALOX5HSD17B1HSD17B2 | |
| SCHEMBL12551064 | 0.82 | HDAC4 (0.43) | ESR1ESR2ALOX5HSD17B1HSD17B2 | |
| SCHEMBL17852145 | 0.82 | ESR1 (0.41) | ESR1ESR2ALOX5HSD17B1HSD17B2 | |
| SCHEMBL17852138 | 0.79 | HSD17B1 (0.44) | ESR1ESR2ALOX5HSD17B1HSD17B2 | |
| SCHEMBL2964464 | 0.79 | ESR1 (0.50) | ESR1ESR2ALOX5HSD17B1HSD17B2 | |
| SCHEMBL269358 | 0.79 | ESR1 (0.50) | ESR1ESR2ALOX5HSD17B1HSD17B2 | |
| SCHEMBL21238074 | 0.76 | ESR1 (0.52) | ESR1ESR2ALOX5HSD17B1HSD17B2 | |
| SCHEMBL19720301 | 0.76 | ESR1 (0.52) | ESR1ESR2ALOX5HSD17B1HSD17B2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170222153-A1 | ANTHRACENE DERIVATIVES, LUMINESCENT MATERIALS AND ORGANIC ELECTROLUMINESCENT DEVICES | IDEMITSU KOSAN CO., LTD. (JP) | 2017-08-03 | — | — | US | disclosed |
| US-9660195-B2 | Anthracene derivative having a phenanthryl group | IDEMITSU KOSAN CO., LTD. (JP) | 2017-05-23 | — | — | US | disclosed |
| US-8822041-B2 | Anthracene derivatives, luminescent materials and organic electroluminescent devices | IDEMITSU KOSAN CO., LTD. (JP) | 2014-09-02 | — | — | US | disclosed |
| US-20140103319-A1 | ANTHRACENE DERIVATIVES, LUMINESCENT MATERIALS AND ORGANIC ELECTROLUMINESCENT DEVICES | IDEMITSU KOSAN CO., LTD. (JP) | 2014-04-17 | — | — | US | disclosed |
| US-20110068683-A1 | ANTHRACENE DERIVATIVES, LUMINESCENT MATERIALS AND ORGANIC ELECTROLUMINESCENT DEVICES | Idemtsu Kosan Co., Ltd | 2011-03-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170222153-A1 | ANTHRACENE DERIVATIVES, LUMINESCENT MATERIALS AND ORGANIC ELECTROLUMINESCENT DEVICES | ANXA7, AAAS, ANXA1 | ESR1 26/4885ESR2 74/4885ALOX5 323/4885 |
| US-20110068683-A1 | ANTHRACENE DERIVATIVES, LUMINESCENT MATERIALS AND ORGANIC ELECTROLUMINESCENT DEVICES | ANXA7, AAAS, ANXA1 | ESR1 26/4885ESR2 74/4885ALOX5 323/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.